Capricor Therapeutics (CAPR) Current Assets: 2011-2025
Historic Current Assets for Capricor Therapeutics (CAPR) over the last 15 years, with Sep 2025 value amounting to $101.0 million.
- Capricor Therapeutics' Current Assets rose 17.63% to $101.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $101.0 million, marking a year-over-year increase of 17.63%. This contributed to the annual value of $163.4 million for FY2024, which is 221.27% up from last year.
- Latest data reveals that Capricor Therapeutics reported Current Assets of $101.0 million as of Q3 2025, which was down 18.67% from $124.1 million recorded in Q2 2025.
- Capricor Therapeutics' Current Assets' 5-year high stood at $163.4 million during Q4 2024, with a 5-year trough of $29.5 million in Q3 2023.
- In the last 3 years, Capricor Therapeutics' Current Assets had a median value of $50.9 million in 2023 and averaged $78.0 million.
- Per our database at Business Quant, Capricor Therapeutics' Current Assets plummeted by 37.84% in 2023 and then surged by 304.73% in 2025.
- Quarterly analysis of 5 years shows Capricor Therapeutics' Current Assets stood at $36.4 million in 2021, then climbed by 17.71% to $42.9 million in 2022, then grew by 18.58% to $50.9 million in 2023, then soared by 221.27% to $163.4 million in 2024, then rose by 17.63% to $101.0 million in 2025.
- Its Current Assets stands at $101.0 million for Q3 2025, versus $124.1 million for Q2 2025 and $146.3 million for Q1 2025.